Reich K, Gordon KB, Strober BE, Armstrong AW, et al. Five-year maintenance of clinical response and improvements in health-related quality of life in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2. Br J Dermatol 2021 Jun 9. doi: 10.1111/bjd.20568.
PMID: 34105767